Bonnaure-Mallet M - Search Results

1

Genetic determinants associated with cfxA-positive clinical Capnocytophaga isolates.

Tamanai-Shacoori Z, Dupont A, Auffret M, Peton V, Barloy-Hubler F, Ehrmann E, Ropert M, Bonnaure-Mallet M, Jolivet-Gougeon A. Tamanai-Shacoori Z, et al. Int J Antimicrob Agents. 2015 Sep;46(3):356-8. doi: 10.1016/j.ijantimicag.2015.05.006. Epub 2015 Jun 19. Int J Antimicrob Agents. 2015. PMID: 26159866 Free article. No abstract available.

2

Antimicrobial treatment of Capnocytophaga infections.

Jolivet-Gougeon A, Sixou JL, Tamanai-Shacoori Z, Bonnaure-Mallet M. Jolivet-Gougeon A, et al. Int J Antimicrob Agents. 2007 Apr;29(4):367-73. doi: 10.1016/j.ijantimicag.2006.10.005. Epub 2007 Jan 23. Int J Antimicrob Agents. 2007. PMID: 17250994 Review.

3

Capnocytophaga spp. involvement in bone infections: a review.

Piau C, Arvieux C, Bonnaure-Mallet M, Jolivet-Gougeon A. Piau C, et al. Int J Antimicrob Agents. 2013 Jun;41(6):509-15. doi: 10.1016/j.ijantimicag.2013.03.001. Epub 2013 May 1. Int J Antimicrob Agents. 2013. PMID: 23642766 Review.

4

High prevalence of β-lactam and macrolide resistance genes in human oral Capnocytophaga species.

Ehrmann E, Handal T, Tamanai-Shacoori Z, Bonnaure-Mallet M, Fosse T. Ehrmann E, et al. J Antimicrob Chemother. 2014 Feb;69(2):381-4. doi: 10.1093/jac/dkt350. Epub 2013 Sep 7. J Antimicrob Chemother. 2014. PMID: 24013195

5

Oral Gram-negative anaerobic bacilli as a reservoir of β-lactam resistance genes facilitating infections with multiresistant bacteria.

Dupin C, Tamanai-Shacoori Z, Ehrmann E, Dupont A, Barloy-Hubler F, Bousarghin L, Bonnaure-Mallet M, Jolivet-Gougeon A. Dupin C, et al. Int J Antimicrob Agents. 2015 Feb;45(2):99-105. doi: 10.1016/j.ijantimicag.2014.10.003. Epub 2014 Nov 3. Int J Antimicrob Agents. 2015. PMID: 25465519 Review.

6

cfxA expression in oral clinical Capnocytophaga isolates.

Tamanai-Shacoori Z, Monfort C, Oliviero N, Gautier P, Bonnaure-Mallet M, Jolivet-Gougeon A. Tamanai-Shacoori Z, et al. Anaerobe. 2015 Oct;35(Pt B):68-71. doi: 10.1016/j.anaerobe.2015.07.005. Epub 2015 Jul 21. Anaerobe. 2015. PMID: 26204794

7

Role of DNA gyrase and topoisomerase IV mutations in fluoroquinolone resistance of Capnocytophaga spp. clinical isolates and laboratory mutants.

Ehrmann E, Jolivet-Gougeon A, Bonnaure-Mallet M, Fosse T. Ehrmann E, et al. J Antimicrob Chemother. 2017 Aug 1;72(8):2208-2212. doi: 10.1093/jac/dkx119. J Antimicrob Chemother. 2017. PMID: 28453633 Free article.

8

Genetic analysis of an ambler class A extended-spectrum beta-lactamase from Capnocytophaga ochracea.

Jolivet-Gougeon A, Tamanai-Shacoori Z, Desbordes L, Burggraeve N, Cormier M, Bonnaure-Mallet M. Jolivet-Gougeon A, et al. J Clin Microbiol. 2004 Feb;42(2):888-90. doi: 10.1128/JCM.42.2.888-890.2004. J Clin Microbiol. 2004. PMID: 14766881 Free PMC article.

9

Prevalence of oropharyngeal beta-lactamase-producing Capnocytophaga spp. in pediatric oncology patients over a ten-year period.

Jolivet-Gougeon A, Tamanai-Shacoori Z, Desbordes L, Gandemer V, Sixou JL, Morvan-Graveline N, Cormier M, Bonnaure-Mallet M. Jolivet-Gougeon A, et al. BMC Infect Dis. 2005 May 9;5:32. doi: 10.1186/1471-2334-5-32. BMC Infect Dis. 2005. PMID: 15882453 Free PMC article.

10

Influence of previous antimicrobial therapy on oral carriage of beta-lactamase producing Capnocytophaga isolates.

Jolivet-Gougeon A, Guérin J, Tamanai-Shacoori Z, Gandemer V, Sixou JL, Bonnaure-Mallet M. Jolivet-Gougeon A, et al. Acta Paediatr. 2008 Jul;97(7):964-7. doi: 10.1111/j.1651-2227.2008.00824.x. Acta Paediatr. 2008. PMID: 18532936

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

136 results

Search Page